![]() ![]() Their achievements and future opportunities reflect the outstanding research and training opportunities available to PhD candidates. Wilkinson are exemplary of the hard work and effort the CB program has invested in their students. ![]() Adam Sowalsky, focusing on genomic changes in prostate cancer that contribute to cancer progression and drug resistance.īoth Dr. Wilkinson has accepted a postdoctoral fellowship position at the NIH in the laboratory of Dr. Additionally, he volunteers for Students for Science, a community outreach organization that brings science education to elementary schools. He is actively involved in cancer education through both the Biology department and the Pre-College Program here at Emory. Wilkinson has a first author paper in Molecular Biology Of The Cell that focuses on defective kinase activity and its role in cancer cell invasion, with a second manuscript currently under review. Adam Marcus who studies tumor escape and metastasis. He was also a recipient of an NRSA award and joined the laboratory of Dr. Scott Wilkinson received his Bachelor of Science degree from Berry College in 2009. Recently, the Cancer Biology program had the privilege of announcing the graduation of their first two doctoral candidates from the inaugural class of 2011. The program is also based out of the Winship Cancer Institute, offering students outstanding opportunities to participate in translational research. The goal of the CB program is to produce exceptional leaders in the field, with a strong foundation in cancer biology and basic research techniques. The CB program has recruited diverse faculty members with backgrounds in both basic science and clinical research, providing a learning platform for their students with excellent multidisciplinary training opportunities. The doctoral program in Cancer Biology (CB) here at Emory University has answered the call accepting their first class of students back in 2011. Physicians would have the ability to use molecularly targeted therapies tailored to an individual’s cancer based on genetic mutations as well as molecular changes. The goals of this project were to advance biomedical research and provide clinicians the tools to offer cancer patients a treatment plan personalized for their disease. In 2016, President Obama included a 215 million dollar investment into his yearly fiscal budget as part of a precision medicine initiative to focus primarily on oncology. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |